Abstract
We describe a successful autologous bone marrow transplant without the use of any blood products. The patient had relapsed large cell lymphoma. He was a Jehovah's Witness and would not accept transfusions of red blood cells or platelets. He enrolled in our Bloodless Medicine and Surgery Program and was maintained on a regimen of erythropoietin, iron, Amicar, and G-CSF throughout the transplant. He tolerated the transplant well and is alive with no evidence of disease 10 months after autografting. Bone Marrow Transplantation (2000) 26, 227–229.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prince HM, Imrie K, Crump M et al. The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of prognostic groups Br J Haematol 1996 92: 880–889
Nevo S, Swan V, Enger C et al. Acute bleeding after bone marrow transplantation – incidence and effect on survival Blood 1998 91: 469–477
McKay PJ, Murphy JA, Camerson S et al. Iron overload and liver dysfunction after allogeneic and autologous bone marrow transplantation Bone Marrow Transplant 1996 17: 63–66
Ford PA and Henry DH . Using r-HuEPO in patients unwilling to accept blood transfusions Erythropoiesis 1996 7: 63–68
Smoller BR, Kruskall MS . Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements New Engl J Med 1986 314: 1233–1235
Rosengart TK, Helm RE, Debois WJ et al. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a ‘bloodless’ surgical technique Am Coll Surg 1997 184: 618–629
Vannucchi AM, Bosi A, Ieri A et al. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial Bone Marrow Transplant 1996 17: 527–531
Vredenburgh JJ, Hussein A, Fisher D et al. A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer Biol Blood Marrow Transplant 1998 4: 134–141
Bartholomew JR, Salgia R, Bell WR . Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid Arch Intern Med 1989 149: 1959–1961
Estrin JT, Ford PA, Henry DH et al. Erythropoietin permits high-dose chemotherapy with peripheral blood stem-cell transplant for a Jehovah's Witness Am J Hematol 1997 55: 51–52
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ballen, K., Ford, P., Waitkus, H. et al. Successful autologous bone marrow transplant without the use of blood product support. Bone Marrow Transplant 26, 227–229 (2000). https://doi.org/10.1038/sj.bmt.1702483
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702483
Keywords
This article is cited by
-
Autologous and allogeneic stem cell transplant in Jehovah’s Witnesses: a single-center experience on 22 patients
Bone Marrow Transplantation (2016)
-
Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases
Supportive Care in Cancer (2010)
-
Successful autologous peripheral blood stem cell transplantation in a Jehovah’s Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products
International Journal of Hematology (2008)
-
The administration of polymerized human hemoglobin (pyridoxylated) to a jehovah's witness after submyeloablative stem cell transplantation complicated by delayed graft failure
Comprehensive Therapy (2006)
-
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience
Bone Marrow Transplantation (2005)